SEARCH RESULT

Total Matching Records found : 171

Natco Pharma bags licence to sell Bayer's cancer drug Nexavar

-The Economic Times   The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

More »

Natco gets India’s first compulsory licence-CH Unnikrishnan

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...

More »

NRHM to soon become National Health Mission by Aarti Dhar

The government proposes to convert the National Rural Health Mission (NRHM) into a National Health Mission to provide health care to the urban poor also, in the course of the 12th Plan. Universal access to free generic essential medicines in public health institutions in a phased and time-bound manner will be ensured. Announcing major initiatives to provide universal healthcare, President Pratibha Patil on Monday said the government would endeavour to increase both...

More »

Novartis vs India: the showdown approaches by Simon Reid-Henry

The Swiss-based pharmaceutical giant Novartis is taking the state of India to court in a case that has, after rumbling about in the lower courts for six years, wound up as a very public litmus test of the legal framework sustaining India’s generic drugs revolution.  With the case due before the Supreme Court on 28 March, the fate of millions who depend on affordable Indian medicines may soon hang in the...

More »

India's global pharmacy role threatened by EU pact

-AP   Efforts by India and the European Union to strengthen trade are threatening India's ability to deliver lifesaving medicines to the world's poorest, analysts say as the two sides push through protracted negotiations on a free-trade pact.  India's prime minister and top EU officials are hoping their summit Friday in New Delhi helps move beyond disagreements over issues like European labor market limits and Indian duties on cars.  But health industry workers and...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close